Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate.

نویسندگان

  • Yee-Leng Teoh
  • Yong-Kwang Tay
چکیده

GPP: generalized pustular psoriasis IL-36RN: interleukin-36 receptor antagonist PV: psoriasis vulgaris INTRODUCTION Generalized pustular psoriasis (GPP) is a rare but serious inflammatory skin disease that may be caused by deficiency of interleukin-36 receptor antagonist in which there is presence of homozygous or compound heterozygous mutations of the IL-36RN gene. Most GPP cases are sporadic, although some may be autosomal recessive. A significant proportion of GPP without psoriasis vulgaris (PV) had homozygous or compound heterozygous mutations in IL-36RN. GPP alone is a distinct subtype and is etiologically distinguished from GPP with PV. Most GPP alone is caused by deficiency of the IL-36RN caused by IL-36RN mutations, in contrast to GPP associated with PV, in which this mutation is usually absent.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Generalized pustular psoriasis in infant with heterozygous mutation in the IL36RN gene successfully treated with infliximab

Introduction Homozygous missense mutation in the IL36RN gene resulting in deficiency of interleukin-36-receptor antagonist (DITRA) is phenotypically presented as severe generalized pustular psoriasis starting in early childhood. Compound heterozygous cases have been described with the same DITRA phenotype, but to our knowledge heterozygous IL36RN mutation related to severe generalized pustular ...

متن کامل

PW02-012 - First clinical description of an infant with DITRA

Introduction Interleukin-36-receptor antagonist deficiency (DITRA) is a recently described auto-inflammatory disease, characterized by repeated flares of generalized pustular psoriasis, high fever, asthenia and systemic inflammation. This condition is caused by homozygous missense mutation in the IL36RN gene, encoding the interleukin-36-receptor antagonist (IL-36Ra), an anti-inflammatory cytoki...

متن کامل

First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra.

YM is the first son of Tunisian consanguineous parents who developed, at 2 weeks of life, an erythematous and scaly eruption, with subsequent rapid evolution toward generalized pustular psoriasis. Afterward, cutaneous flares of diffuse erythematous rash and pustules involving the whole body appeared, with a once weekly periodicity. Intense irritability was present during flares without fever. M...

متن کامل

Unprocessed interleukin-36α regulates psoriasis-like skin inflammation in co-operation with interleukin-1

Generalized pustular psoriasis is a severe skin disease characterized by epidermal hyperplasia, neutrophil-rich abscesses within the epidermis, and a mixed inflammatory infiltrate in the dermis. The disease may be caused by missense mutations in the IL-36 receptor antagonist, IL-36Ra. Curiously, the related IL-1Ra has therapeutic effects in some of these latter patients. Here, using an experime...

متن کامل

Top accessed article: dermoscopic examination of nail pigmentation.

Circulation. 2005;111(23):3135-3140. 19. Horai R, Nakajima A, Habiro K, et al. TNFis crucial for the development of autoimmune arthritis in IL-1 receptor antagonist–deficient mice. J Clin Invest. 2004; 114(11):1603-1611. 20. Shepherd J, Little MC, Nicklin MJ. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol. 2004;122(3):665669. 21. Nakae...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • JAAD case reports

دوره 1 2  شماره 

صفحات  -

تاریخ انتشار 2015